AGA update sets limits on endoscopic surveillance in older adults
-
August 24
“It may very well be reasonable to stop Barrett's surveillance or at least give patients the option to stop,” said first author Audrey H. Calderwood, MD, MS.
BROWSE BY TOPICS
Esophagus
Pancreas
Biliary tract
Small bowel
Colon
Stomach
-
Obesity
-
Alcohol-related liver disease
-
Biliary tract cancer
-
Colorectal cancer
-
Esophageal cancer
-
Liver cancer
-
Celiac disease
-
Cirrhosis
-
Diarrhea and constipation
-
Diet and nutrition
-
Eosinophilic GI diseases
-
Eosinophilic esophagitis
-
Hepatic encephalopathy
-
IBD
-
Crohn's disease
-
Ulcerative colitis
-
IBS
-
Infections
-
C. diff
-
MASLD and MASH
-
Short bowel syndrome
-
Pancreatic diseases and conditions
-
GERD and Barrett’s esophagus
Career & professional development
Diversity, equity, and inclusion
Health, wellness, and burnout
Patient advocacy and equity
Practice management
Coding, coverage, and reimbursement
Technology & innovation
Endoscopy
Substance use disorders in gastroenterology and hepatology: A practical guide for the general gastroenterologist
-
August 3
-
by Isabelle S. Byers, MD, Michelle Russin, MD, Sasha Deutsch-Link, MD, MSCR
GI and liver complications often bring these patients in first, and the authors say gastroenterologists are well placed to screen and treat.
Bridging the rural divide: Building a motility center in a critical access hospital
-
August 3
-
by Amber Charoen, MD, W. Michael McDonnell, MD, AGAF
“If large urban centers can run comprehensive motility labs, why can't a critical access hospital?”
Is professional coaching worth it? A practical guide for early-career gastroenterologists
-
August 3
-
by Mariam Naveed, MD, FACG, Kathryn E. Hutchins, MD, FACG
Two program directors on why coaching belongs at the start of a GI career, not after something has already gone wrong.
The Latest
AGA update sets limits on endoscopic surveillance in older adults
-
by Doug Brunk
“It may very well be reasonable to stop Barrett's surveillance or at least give patients the option to stop,” said first author Audrey H. Calderwood, MD, MS.
A tribute to our readers: A farewell from TNG's editor-in-chief
-
by Judy A. Trieu, MD, MPH
After four years leading The New Gastroenterologist, Judy A. Trieu, MD, MPH, signs off with a final issue on substance use disorders, behavioral health, coaching, and social media ethics.
More than one sugary drink a day tied to double gastric cancer risk
-
by Doug Brunk
“If this association holds up in future research, it means there may be a meaningful, actionable way for people to lower their risk of a cancer that is often diagnosed late and is difficult to treat.”
Consensus panel: post-ESD pathology reports should assess risk, not just confirm cancer
-
by Meg Barbor
Forty-two experts from 15 countries issued 56 recommendations on invasion depth, margins, and tumor budding to guide what happens after resection.
Rome V criteria capture more people with IBS, but a milder group
-
by Doug Brunk
Seventy percent of UK registry participants met the revised criteria vs. 59% under Rome IV, but those Rome V excluded had far more severe symptoms, more psychological comorbidity and higher costs.
